MIRA
INFORM REPORT
|
Report Date : |
24.01.2008 |
IDENTIFICATION
DETAILS
|
Name : |
JABER EBNE HAYYAN PHARMA COMPANY |
|
|
|
|
Registered Office : |
4th Km. fo Karaj Special Road, Tehran |
|
|
|
|
Country : |
Iran |
|
|
|
|
Financials (as on) : |
29/03/2006 |
|
|
|
|
Date of Incorporation : |
1960 |
|
|
|
|
Com. Reg. No.: |
7646 |
|
|
|
|
Legal Form : |
Public Joint Stock Company |
|
|
|
|
Line of Business : |
Production of pharmaceutical preparations for the cardiovascular system,
central and autonomic nervous system. |
RATING &
COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
No complaints |
|
|
|
|
Litigation : |
Clear |
COMPANY DETAILS
Reference No : 47034
Company Name : Jaber Ebne Hayyan Pharma Company
Headquarter Address : 4th Km. fo Karaj Special Rd
Tehran
Iran
P. O. Box : 13185 1739
Tel : +98 21 44503323
+98 21 44503324
+98 21 44503325
+98 21 44503326
+98 21 44503327
Fax : +98 21 44503530
Website : www.jaber-pharma.com
E-mail : headoffice@jaber-pharma.com
REGISTRATION AND LEGAL DETAILS
Current Legal Form : Public Joint Stock Company
Registration Address : 4th
Km. fo Karaj Special Rd.
Tehran
Iran
Registration Number : 7646
Registration Date : 1960
Year Established : 1960
Registration Town : Tehran
CAPITAL
Currency : Iranian Rials
Nominal capital : 189,000,000,000
Number of Shares : 189,000,000
Type of Shares : None Selected
Issued Shares: -Value per share: IRI 1,000.00
SHAREHOLDERS
|
Shareholder Names/
Address |
% of Voting/Non-Voting
Capital |
|
Shafa
Darou Investment Tehran Iran |
%20 |
|
Bank Melli Investment Company Tehran Iran |
%30 |
|
Kimidarou Pharmaceutical Company Tehran Iran |
%12 |
|
Others Iran |
%21 |
|
Pakhsh Razi Company Tehran Iran |
%17 |
PRINCIPALS
Name : Mr. Hossein Mohamadi Torbati
Position within the company : Chairman
Country of Birth : Iran
Nationality : Iranian
Can fluently speak : Farsi- English
Name : Mr. Abbas Ali
Asadollahbeyk
Position within the company : Member
Country of Birth : Iran
Nationality : Iranian
Can fluently speak : Farsi, English
Name : Mr. Ali Montaseri
Position within the company : Managing Director
Country of Birth : Iran
Nationality : Iranian
Can fluently speak : Farsi, English
Name : Mr. Mahmoud Abhari
Position within the company : Member
Country of Birth : Iran
Nationality : Iranian
Can fluently speak : Farsi, English
Name : Mr. Seyed Ali Salehi Amiri
Position within the company : Vice Chairman
Country of Birth : Iran
Nationality : Iranian
Can fluently speak : Farsi- English
COMPANY ACTIVITIE
Production of
Pharmaceutical preparations for the cardiovascular system, central and
autonomic nervous system
Pharmaceutical
preparations for metabolism, nutrition, alimentary systems. Pharmaceutical preparations
for urology, dermatology, gynaecology and obstetrics Chemotherapeutic agents,
endocrines, antiseptics, immunological preparations
Local Reporters consider the investigated company to be Large their field of concern.
OPERATIONS
EMPLOYEE
Company Employs : 385
HQ PREMISES
Operates from : Owned Offices, Warehouses, Factory
Location : Central Business Area, Main Road
IMPORTS
Imports : Raw Material
Import% : 20%
Import from :
Western Europe, Asia Pacific
Import terms :
letters of credit
Additional :
balance of 80% purchased via local market
EXPORT
Exports : Finished Goods
Export% : 20%
Export to : Persian Gulf Countries, CIS, Afghanistan
Export terms :
letters of credit
TRADING & SELLING
Territory : 80% Nationality, 20 %
Internationally
Type of Customer : General Public, Local Authorities
Terms of sales : Cash, letters of credit
Vehicles : Total number of vehicles: 90
RELATED COMPANIES
Subject dose not
have related company
BANKS
Ø
Bank Saderat, Tehran, Iran
Ø
Bank Melli, Tehran, Iran
Ø
Bank Sepah, Tehran, Iran
FINANCIAL INFORMATION
Source : Mr. Alireza Sadeghi (Director)
Currency : Iranian Rials - 000,000
|
Months |
Date |
Sales |
Gross |
Net |
|
12 |
29/03/2007 |
1065070 |
298056 |
210735 |
|
12 |
29/03/2006 |
814300 |
188602 |
141865 |
|
12 |
29/03/2005 |
731401 |
169030 |
135080 |
BALANCE SHEET
Source : Financial Estimates on
29/03/2006
Currency : Iranian Rials
Note : Figures in 000,000
|
NEW WORTH |
176100 |
|
Trade Creditor |
91400 |
|
Total Liabilities |
152000 |
|
|
|
|
Trade Debtors |
82500 |
|
Total Assets |
337000 |
PAYMENTS
Subject's payments reported to be : NO COMPLAINTS
INTERVIEW & REPORTER COMMENTS
Name/Title : Mr. Alireza Sadeghi (Director)
In the interview conducted with Mr. Alireza Sadeghi (Director).
He
declined bank account numbers citing the grounds of Company
confidentiality.
CONCLUSION
Local Reputation:
The company being investigated is considered by local reporters to be a Normal Trade Risk.
General Conclusion
Local informants consider granting of credit to be a fair trade risk.
Owner/Shareholders Comments:
Some of owners involved in the running of
the business
Age of Business: Old Business
RATING
EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest capability
for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Unfavourable & favourable factors carry similar weight in credit
consideration. Capability to overcome financial difficulties seems
comparatively below average/normal. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
NR |
In view of the lack of information, we have no basis upon which to
recommend credit dealings |
No Rating |
|
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this
report. The assessed factors and their relative weights (as indicated through
%) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)